AOD-9604

AOD-9604 is a modified fragment of human growth hormone (hGH), specifically corresponding to amino acids 176–191, engineered to retain lipolytic (fat-reducing) properties while minimizing anabolic or growth-promoting effects. It functions by stimulating lipolysis and inhibiting lipogenesis through pathways associated with fat metabolism, without significantly impacting insulin sensitivity or IGF-1 levels. This selective activity has made it a subject of interest in obesity and metabolic research.

Preclinical and clinical investigations have indicated that AOD-9604 may promote the breakdown of stored adipose tissue and support weight reduction, particularly in conjunction with diet and lifestyle interventions. Studies suggest it may also have a favorable safety profile compared to full-length growth hormone, with minimal effects on blood glucose regulation. Despite these findings, results across human trials have been mixed, and further large-scale studies are needed to confirm its long-term efficacy and therapeutic potential in metabolic disorders.